Ibuprofen
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Ibumax 200 mg contains ibuprofen, a substance from the group of nonsteroidal anti-inflammatory drugs (NSAIDs), with analgesic, antipyretic, and anti-inflammatory effects.
The indications for use of the medicine are:
Before starting treatment with Ibumax 200 mg, the patient should discuss it with their doctor or pharmacist.
There is a risk of gastrointestinal bleeding, ulceration, or perforation, which can be fatal and do not necessarily have to be preceded by warning signs or may occur in patients who have had such warning signs.
In case of gastrointestinal bleeding or ulceration, ibuprofen treatment should be discontinued.
Patients with a history of gastrointestinal diseases, especially the elderly, should inform their doctor about any unusual gastrointestinal symptoms (especially bleeding), especially during the initial treatment period.
During ibuprofen treatment, allergic reactions to this medicine have occurred, including difficulty breathing, facial and neck edema (angioedema), chest pain.
If the patient notices any of these symptoms, they should immediately stop taking Ibumax 200 mg and seek medical help immediately.
Concomitant, prolonged use of painkillers may lead to kidney damage with a risk of kidney failure (analgesic nephropathy).
Taking anti-inflammatory/pain-relieving medicines, such as ibuprofen, may be associated with a slight increase in the risk of heart attack or stroke, especially when used in high doses.
Do not exceed the recommended dose and duration of treatment.
Before taking Ibumax 200 mg, the patient should discuss the treatment with their doctor or pharmacist if:
Skin reactions
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP) have been reported with ibuprofen use.
If the patient experiences any symptoms associated with these severe skin reactions described in section 4, they should immediately stop taking Ibumax 200 mg and seek medical attention.
Infections
Ibumax 200 mg may mask the symptoms of infection, such as fever and pain.
Therefore, Ibumax 200 mg may delay the use of appropriate infection treatment and lead to increased risk of complications.
This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox.
If the patient takes this medicine while having an infection and the infection symptoms persist or worsen, they should immediately consult a doctor.
In elderly patients, there is an increased risk of side effects associated with ibuprofen use compared to younger patients.
The frequency and severity of side effects can be reduced by using the smallest effective dose for the shortest possible duration.
The patient should consult a doctor, even if the above warnings refer to past situations.
The medicine is not intended for use in children under 12 years of age.
There is a risk of kidney failure in dehydrated adolescents.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Ibumax 200 mg should not be taken if the patient is taking other nonsteroidal anti-inflammatory drugs (including COX-2 inhibitors, such as celecoxib or etoricoxib), other painkillers, or acetylsalicylic acid (in pain-relieving doses).
Ibumax 200 mg may affect the action of other medicines or other medicines may affect the action of Ibumax 200 mg.
For example:
Also, some other medicines may be affected or have an effect on Ibumax 200 mg treatment.
Therefore, before taking Ibumax 200 mg with other medicines, the patient should always consult their doctor or pharmacist.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
Ibumax 200 mg should not be taken if the patient is in the last 3 months of pregnancy, as it may harm the unborn child or cause complications during delivery.
Ibumax 200 mg may lead to kidney and heart dysfunction in the unborn child.
It may increase the risk of bleeding in the mother and child and cause prolongation or prolongation of labor.
During the first 6 months of pregnancy, Ibumax 200 mg should not be used unless the doctor considers it absolutely necessary.
If treatment is necessary during this period or when trying to conceive, the smallest effective dose should be used for the shortest possible duration.
If Ibumax 200 mg is taken by a woman from the 20th week of pregnancy for more than a few days, it may cause kidney dysfunction in the unborn child, leading to low amniotic fluid levels (oligohydramnios) or narrowing of the arterial duct (ductus arteriosus) in the child's heart.
If the patient requires treatment for a longer period, additional fetal monitoring should be recommended.
Breastfeeding
Ibuprofen may pass into breast milk in small amounts.
Since there are no reports of harmful effects of ibuprofen on infants, breastfeeding does not need to be discontinued during short-term use of ibuprofen in small doses.
Fertility
This medicine belongs to a group of medicines (nonsteroidal anti-inflammatory drugs) that may adversely affect female fertility.
This effect is temporary and disappears after the end of treatment.
If the patient experiences difficulty conceiving, they should consult their doctor before taking ibuprofen.
There are no data on the effect of Ibumax 200 mg on the ability to drive vehicles, operate machinery, and psychophysical fitness during use in recommended doses and for the recommended duration.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
In case of doubt, the patient should consult their doctor or pharmacist.
The smallest effective dose should be used for the shortest possible duration to relieve symptoms.
If the patient has an infection and the infection symptoms (such as fever and pain) persist or worsen, they should immediately consult a doctor (see section 2).
The medicine is intended for oral use only in adults and adolescents over 12 years of age.
Adults and adolescents over 12 years of age: The initial dose is one or two tablets.
Then, if necessary, one or two tablets every four hours.
Within 24 hours, no more than six tablets should be taken (maximum daily dose 1200 mg in divided doses).
If the product is used in adolescents for more than 3 days, or if symptoms worsen, the patient should consult a doctor.
Elderly patients: no dose adjustment is required.
Do not exceed the recommended dose!
If the patient feels that the effect of Ibumax 200 mg is too strong or too weak, they should consult their doctor.
The medicine is intended for short-term use.
The smallest effective dose should be used for the shortest possible duration.
This reduces the risk of side effects.
The medicine should not be taken for more than 3 days unless the doctor has prescribed otherwise.
Overdose cases are rare.
During severe poisonings, metabolic acidosis may occur, and the prothrombin time (INR) may be increased.
The following may occur: acute kidney failure or liver damage.
In patients with asthma, worsening of asthma symptoms may occur.
If the patient has taken a higher dose of Ibumax 200 mg than recommended or if a child has accidentally taken the medicine, they should always consult a doctor or go to the nearest hospital to get an opinion on possible health risks and advice on what to do.
Overdose symptoms may include nausea, abdominal pain, vomiting (which may contain blood), gastrointestinal bleeding (see also section 4 below), diarrhea, headache, tinnitus (ringing in the ears), and disorientation.
They may also include agitation, drowsiness, disorientation, or coma.
Rarely, patients may experience seizures.
After taking large doses, drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness have been reported, as well as blood in the urine, low potassium levels in the blood, feeling cold, and difficulty breathing.
Additionally, the prothrombin time (INR) may be prolonged, probably due to the disruption of blood clotting factors.
Acute kidney failure and liver damage may occur.
In patients with asthma, worsening of asthma symptoms may occur.
Additionally, low blood pressure and difficulty breathing may occur.
There is no specific antidote.
Supportive and symptomatic treatment is used, which involves removing the medicine from the body.
The doctor should monitor vital signs and consider oral administration of activated charcoal within 1 hour of overdose.
In case of frequent or prolonged seizures, intravenous diazepam or lorazepam should be administered.
In case of asthma patients, bronchodilators should be administered.
A double dose should not be taken to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If the patient experiences any of the following symptoms, they should immediately stop taking ibuprofen and seek medical attention:
Side effects that occur not very often (in 1 to 10 out of 1000 patients taking the medicine):
Side effects that occur rarely (in 1 to 10 out of 10,000 patients taking the medicine):
Side effects that occur very rarely (less than 1 in 10,000 patients taking the medicine):
Side effects with unknown frequency (frequency cannot be estimated from available data):
Taking medicines like ibuprofen may be associated with a slight increase in the risk of heart attack (myocardial infarction) or stroke.
If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should tell their doctor or pharmacist.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
PL-02 222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medicine.
No special storage precautions.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste.
The patient should ask their pharmacist how to dispose of medicines that are no longer needed.
This will help protect the environment.
1 coated tablet contains:active substance: ibuprofen, 200 mg
excipients: maize starch, potato starch, hypromellose, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, stearic acid, colloidal anhydrous silica; coating
Ibumax 200 mg: 6, 10, 12, 20, 24, 30, 50 coated tablets (aluminum/PVC or aluminum/PVC/PVDC blisters) in a cardboard box.
Vitabalans Oy
Varastokatu 8
13500 Hämeenlinna
Finland
Phone: +358 3 615 600
To obtain more detailed information about this medicine, the patient should contact the local representative of the marketing authorization holder:
Vitabalans Sp. z o.o.
ul. Narbutta 5 m 1
02-564 Warsaw
info-pl@vitabalans.com
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.